The organization is leveraging its growing bank of whole-slide pathology images to create models that could form the backbone of cancer testing applications.
Tanla Platforms tumbled 6.14% to Rs 623.95 after the company's consolidated net profit declined 15.43% to Rs 118.51 crore on 0.21% fall in net sales to Rs 1,000.43 crore in Q3 FY25 over Q3 FY24.
"Yanbin (Eric) Qiang’s leadership exemplifies collaborative excellence and agility in addressing market needs through innovative market strategies. Under his guidance, MUSE Microscopy is poised to ...